Cited by 473Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsGenetic Associations and Epidemiology

The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

Wilson, Peter W. F.·1994·JAMA

DOI 10.1001/jama.1994.03520210050031

Open this paper in CoChat — free account

Abstract

Objective To describe the association between apolipoprotein E alleles (epsilon 2, epsilon 3, and epsilon 4), dyslipidemias, and coronary heart disease (CHD). Design Cross-sectional prevalence study. Setting and participants Community-based sample of men (n = 1034) and women (n = 916) aged 40 to 77 years who are participating in a long-term study of cardiovascular disease. Study participants underwent fasting lipid measurements, coronary risk factor determinations, and a comprehensive evaluation for the presence of current or previous CHD. Results Compared with the epsilon 3 allele, the epsilon 4 allele was associated with elevated low-density lipoprotein cholesterol values (> or = 4.14 mmol/L [160 mg/dL]) in women, the epsilon 2 and epsilon 4 alleles were associated with moderately elevated triglyceride values (> or = 2.82 mmol/L [250 mg/dL]) in men, and the epsilon 2 allele was associated with severely elevated triglyceride values (> or = 5.64 mmol/L [500 mg/dL]) in men. The apolipoprotein E alleles were not associated with hypertension, obesity, smoking, or diabetes, but the epsilon 4 allele frequency was reduced in women after 60 years of age. The age-adjusted prevalence of CHD was associated with the epsilon 4 allele in both men (relative odds = 1.53, P = .04) and women (relative odds = 1.99, P = .05). In analyses for women and for both sexes combined, this relation persisted after adjustment by hypertension, smoking, obesity, diabetes, high-density lipoprotein cholester…

Integrity signals

Registry

Crossref · 10.1001/jama.1994.03520210050031

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,154
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9649 · Cited by 1,525
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363

Show all 59 references

Sorted by citations

Items 101–200 of 473

Is the apoE4 allele an independent predictor of coronary events?
Scuteri, A., Bós, Â. J. G., Zonderman, A. B., Brant, L. J., Lakatta, E. G., & Fleg, J. L. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00639-2 · Cited by 76
Apolipoprotein E Polymorphism Is Associated With Segment-Specific Extracranial Carotid Artery Intima-Media Thickening
Terry, J. G., Howard, G., Mercuri, M. F., Bond, M. G., & Crouse, J. R. (1996) · Stroke · doi:10.1161/01.str.27.10.1755 · Cited by 75
Genetics of coronary heart disease: Current knowledge and research principles
Winkelmann, B. R., Hager, J., Kraus, W. E., Merlini, P. A., Keavney, B. D., Grant, P. J., Muhlestein, J. B., & Granger, C. B. (2000) · American Heart Journal · doi:10.1067/mhj.2000.109636 · Cited by 74
The impact of APOE genotype on survival: Results of 38,537 participants from six population-based cohorts (E2-CHARGE)
Wolters, F. J., Yang, Q., Biggs, M. L., Jakobsdottir, J., Li, S., Evans, D. S., Bis, J. C., Harris, T. B., Vasan, R. S., Zilhao, N. R., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0219668 · Cited by 74
ApoE, Alzheimer's Disease, and Recovery from Brain Stressa
Roses, A. D., & Saunders, A. M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48471.x · Cited by 72
Ionizing radiation and genetic risks
Sankaranarayanan, K., & Chakraborty, R. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(00)00106-8 · Cited by 72
Synergistic Effect between Apolipoprotein E and Angiotensinogen Gene Polymorphisms in the Risk for Early Myocardial Infarction
Batalla, A., Álvarez, R., Reguero, J. R., Hevia, S., Iglesias-Cubero, G., Álvarez, V., Cortina, A., González, P., Celada, M., Medina, A., et al. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.1910 · Cited by 71
Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins
Gómez‐Coronado, D., Álvarez, J. J., Bueno, A. E., Olmos, J. M., Herrera, E., & Lasunción, M. A. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00168-9 · Cited by 71
Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
Wilkinson, M. J., Lepor, N. E., & Michos, E. D. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028892 · Cited by 70
Impact of Sample Selection on APOE ∈4 Allele Frequency: A Comparison of Two Alzheimer's Disease Samples
Tsuang, D., Kukull, W., Sheppard, L., Barnhart, R. L., Peskind, E., Edland, S. D., Schellenberg, G., Raskind, M., & Larson, E. B. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01836.x · Cited by 69
The National Institute on Aging/Alzheimer's Association Recommendations on the Application of Apolipoprotein E Genotyping to Alzheimer's Diseasea
Relkin, N. R., Kwon, Y. J., Tsai, J., & Gandy, S. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32608.x · Cited by 69
Genetic Variation of the Renin-Angiotensin System and Chronic Kidney Disease Progression in Black Individuals in the Atherosclerosis Risk in Communities Study
Hsu, C. C.-C., Bray, M. S., Kao, W. H. L., Pankow, J. S., Boerwinkle, E., & Coresh, J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005050468 · Cited by 69
Combined effects of lipoprotein lipase and apolipoprotein E polymorphisms on lipid and lipoprotein levels in the Stanislas cohort
Salah, D., Bohnet, K., Gueguen, R., Siest, G., & Visvikis‐Siest, S. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37215-1 · Cited by 68
Puzzling role of genetic risk factors in human longevity: “risk alleles” as pro-longevity variants
Ukraintseva, S. V., Yashin, A. I., Arbeev, K. G., Kulminski, A. M., Akushevich, I. V., Wu, D., Joshi, G., Land, K. C., & Stallard, E. (2015) · Biogerontology · doi:10.1007/s10522-015-9600-1 · Cited by 68
Emerging Noninvasive Biochemical Measures to Predict Cardiovascular Risk
Pahor, M., Elam, M. B., Garrison, R. J., Kritchevsky, S. B., & Applegate, W. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.3.237 · Cited by 67
A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype.
Payami, H., Grimslid, H., Oken, B., Camicioli, R. M., Sexton, G. J., Dame, A., Howieson, D. B., & Kaye, J. A. (1997) · PubMed · Cited by 66
Gene-Environment Interaction in Alzheimer’s Disease:A Potential Role for Cholesterol
Chandra, V., & Pandav, R. S. (1998) · Neuroepidemiology · doi:10.1159/000026175 · Cited by 66
Association of apolipoprotein (Apo)E genotype with plasma apo E levels
Larson, I. A., Ordovás, J. M., DeLuca, C., Barnard, J. R., Feussner, G., & Schaefer, E. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00280-4 · Cited by 64
Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study
Caselli, R. J., Osborne, D., Reiman, E. M., Hentz, J. G., Barbieri, C. J., Saunders, A. M., Hardy, J., Graff‐Radford, N. R., Hall, G. R., & Alexander, G. E. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00577-9 · Cited by 62
Association of Apolipoprotein Genetic Polymorphisms With Plasma Cholesterol in a Japanese Rural Population
Zaman, M. M., Ikemoto, S., Yoshiike, N., Date, C., Yokoyama, T., & Tanaka, H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.12.3495 · Cited by 61
Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis
Watson, M. A., Gay, L. J., Stebbings, W., Speakman, C., Bingham, S. A., & Loktionov, A. (2003) · Clinical Science · doi:10.1042/cs20020329 · Cited by 61
Association of Apolipoprotein E Polymorphism with Myocardial Infarction in Greek Patients with Coronary Artery Disease
Kolovou, G. D., Yiannakouris, N., Hatzivassiliou, M., Malakos, J. S., Daskalova, D. C., Hatzigeorgiou, G., Cariolou, M. A., & Cokkinos, D. V. (2002) · Current Medical Research and Opinion · doi:10.1185/030079902125000444 · Cited by 61
Patients with an ApoE ϵ4 allele require lower doses of coumarin anticoagulants
Visser, L. E., Trienekens, P. H., Smet, P. A. G. M. D., Vulto, A. G., Albert Hofman, D., van Duijn, C. M., & Stricker, B. H. C. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200502000-00002 · Cited by 61
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid‐lowering in primary care
Eriksson, M., Hådell, K., Holme, I., Walldius, G., & Kjellström, T. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00294.x · Cited by 61
Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases.
Shajith Anoop, S., Misra, A., Meena, K., & Luthra, K. (2010) · PubMed · Cited by 60
Untitled work
(2000) · doi:10.1002/1098-2272(200101)20:1
The association between APOE and dementia does not seem to be mediated by vascular factors
Prince, M. J., Lovestone, S., Cervilla, J. A., Joels, S., Powell, J. F., Russ, C., & MANN, A. H. (2000) · Neurology · doi:10.1212/wnl.54.2.397 · Cited by 60
Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation
Whitman, S. C., Miller, D. B., Wolfe, B. M., Hegele, R. A., & Huff, M. W. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.9.1707 · Cited by 59
Selection on Alleles Affecting Human Longevity and Late-Life Disease: The Example of Apolipoprotein E
Drenos, F., & Kirkwood, T. B. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010022 · Cited by 59
Racial Differences in the Association Between Apolipoprotein E Risk Alleles and Overall and Total Cardiovascular Mortality Over 18 Years
Rajan, K. B., Barnes, L. L., Wilson, R. S., McAninch, E. A., Weuve, J., Sighoko, D., & Evans, D. A. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15059 · Cited by 59
Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: a pilot study
Loktionov, A., Bingham, S. A., Vorster, H. H., Jerling, J. C., Runswick, S. A., & Cummings, J. H. (1998) · British Journal Of Nutrition · doi:10.1079/bjn19980024 · Cited by 59
Women have a larger and less atherogenic low density lipoprotein particle size than men
Nikkilä, M. T., Pitkäjärvi, T., Koivula, T. A., Solakivi, T., Lehtimäki, T. J., Laippala, P. J., Jokela, H., Lehtom̈aki, E., Seppä, K., & Sillanaukee, P. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05645-9 · Cited by 59
Apolipoprotein E genotypes and risk of diabetic nephropathy.
Onuma, T., Laffel, L. M., Angelico, M. C., & Królewski, A. S. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v771075 · Cited by 59
Influence of the apolipoprotein E ε4 allele on human embryonic development
Zetterberg, H., Palmér, M. S., Ricksten, A., Poirier, J., Palmqvist, L., Rymo, L., Zafiropoulos, A., Arvanitis, D. A., Spandidos, D. A., & Blennow, K. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00198-2 · Cited by 59
Cerebral hemodynamics of the aging brain: risk of Alzheimer disease and benefit of aerobic exercise
Tarumi, T., & Zhang, R. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00006 · Cited by 59
Evidence That the Apolipoprotein E-Genotype Effects on Lipid Levels Can Change with Age in Males: A Longitudinal Analysis
Jarvik, G. P., Goode, E. L., Austin, M. A., Auwerx, J. H., Deeb, S. S., Schellenberg, G. D., & Reed, T. (1997) · The American Journal of Human Genetics · doi:10.1086/513902 · Cited by 57
Genotypng:Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence
Winkelmann, B. R., & Hager, J. (2000) · Pharmacogenomics · doi:10.1517/14622416.1.1.73 · Cited by 57
The Effect of Dietary Fat on LDL Size Is Influenced by Apolipoprotein E Genotype in Healthy Subjects
Moreno, J. A., Pérez‐Jiménez, F., Marı́n, C., Gómez, P., Pérez‐Martínez, P., Moreno‐Luna, R., Bellido, C., Fuentes, F. J., & López‐Miranda, J. (2004) · Journal of Nutrition · doi:10.1093/jn/134.10.2517 · Cited by 57
Plasminogen activator inhibitor‐1 and apolipoprotein E gene polymorphisms and diabetic angiopathy
Tarnow, L., Stehouwer, C. D. A., EMEIS, J. J., Poirier, O., Cambien, F., Hansen, B. V., & Parving, H. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.5.625 · Cited by 57
Genotypes with the apolipoprotein Â4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men
Stengård, J., Pekkanen, J., Ehnholm, C., Nissinen, A. M., & Sing, C. F. (1996) · Human Genetics · doi:10.1007/bf02281882 · Cited by 56
Effect of apolipoprotein e polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients
Güz, G., Özdemir, F. N., Sezer, S., Işıklar, I., Arat, Z., Turan, M., & Haberal, M. A. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.17682 · Cited by 55
Statin use and the risk of Alzheimer's disease: The MIRAGE Study
Green, R. C., McNagny, S. E., Jayakumar, P., Cupples, L. A., Benke, K. S., Farrer, L. A., & MIRAGE Study Group (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.02.003 · Cited by 55
Apolipoprotein E polymorphism and carotid artery intima-media thickness in a random sample of middle-aged men
Ilveskoski, E., Loimaala, A., Mercuri, M. F., Lehtimäki, T. J., Pasanen, M. E., Nenonen, A., Oja, P., Bond, M. G., Koivula, T. A., Karhunen, P. J., et al. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00383-x · Cited by 54
Apolipoprotein E Polymorphism and Atherosclerosis
Kolovou, G. D., Daskalova, D. C., & Mikhailidis, D. P. (2003) · Angiology · doi:10.1177/000331970305400108 · Cited by 54
Association of apolipoprotein E polymorphism with blood lipids and maximal oxygen uptake in the sedentary state and after exercise training in the HERITAGE family study
Leon, A. S., Togashi, K., Rankinen, T., Després, J., Rao, D. C., Skinner, J. S., Wilmore, J. H., & Bouchard, C. (2003) · Metabolism · doi:10.1016/j.metabol.2003.08.013 · Cited by 54
Isoform-Dependent Cholesterol Efflux From Macrophages by Apolipoprotein E Is Modulated by Cell Surface Proteoglycans
Hara, M., Matsushima, T., Satoh, H., Iso-o, N., Noto, H., Togo, M., Kimura, S., Hashimoto, Y., & Tsukamoto, K. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000054199.78458.4b · Cited by 53
Effects of Coenzyme Q10 on TNF‐α secretion in human and murine monocytic cell lines
Schmelzer, C., Lorenz, G., Lindner, I., Rimbach, G. H., Niklowitz, P., Menke, T., & Döring, F. (2007) · BioFactors · doi:10.1002/biof.5520310104 · Cited by 53
Identification of genetic heterogeneity of Alzheimer's disease across age
Lo, M., Kauppi, K., Fan, C.-C., Sanyal, N., Reas, E. T., Sundar, V. S., Lee, W., Desikan, R. S., McEvoy, L. K., & Chen, C. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.02.022 · Cited by 53
Apolipoprotein E polymorphism is associated with both carotid and coronary atherosclerosis in patients with coronary artery disease
Granér, M., Kahri, J., Varpula, M., Salonen, R. M., Nyyssönen, K., Jauhiainen, M., Nieminen, M. S., Syvänne, M., & Taskinen, M.-R. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.003 · Cited by 53
Genetics of menopause-associated diseases
Massart, F., Reginster, J., & Brandi, M. L. (2001) · Maturitas · doi:10.1016/s0378-5122(01)00283-3 · Cited by 53
Apolipoprotein E and Change in Episodic Memory in Blacks and Whites
Barnes, L. L., Arvanitakis, Z., Yu, L., Kelly, J., Jager, P. L. D., & Bennett, D. A. (2013) · Neuroepidemiology · doi:10.1159/000342778 · Cited by 52
Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG
Mackensen, G. B., Swaminathan, M., Ti, L. K., Grocott, H. P., Phillips‐Bute, B. G., Mathew, J. P., Newman, M. F., Milano, C. A., & Stafford‐Smith, M. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.02.106 · Cited by 51
Genetic and Genomic Discovery Using Family Studies
Borecki, I. B., & Province, M. A. (2008) · Circulation · doi:10.1161/circulationaha.107.714592 · Cited by 51
Apolipoprotein E Genotype and Circulating Interleukin-10 Levels in Patients With Stable and Unstable Coronary Artery Disease
Tziakas, D. N., Chalikias, G. K., Antonoglou, C., Veletza, S. V., Tentes, I. K., Kortsaris, A. X., Hatseras, D., & Kaski, J. C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.032 · Cited by 51
Association of APOE ε2/ε3/ε4 and promoter gene variants with dementia but not cardiovascular mortality in old age
Heijmans, B. T., Slagboom, P. E., Gussekloo, J., Droog, S., Lagaay, A. M., Kluft, C., Knook, D. L., & Westendorp, R. G. J. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10142 · Cited by 50
Increased density of cortical apolipoprotein E immunoreactive neurons in rabbit brain after dietary administration of cholesterol
Sparks, D. L., Liu, H., Gross, D. R., & Scheff, S. W. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11357-6 · Cited by 39
Apolipoprotein E polymorphism and lipid levels differ by gender and family history of diabetes: the Rancho Bernardo Study
Oh, J., & Barrett-Connor, E. L. (2001) · Clinical Genetics · doi:10.1034/j.1399-0004.2001.600207.x · Cited by 49
Common gene variants, mortality and extreme longevity in humans
Heijmans, B. T., Westendorp, R. G. J., & Slagboom, P. E. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00171-6 · Cited by 49
Apolipoprotein E Gene Polymorphism and Risk for Coronary Heart Disease in the Chinese Population: A Meta-Analysis of 61 Studies Including 6634 Cases and 6393 Controls
Zhang, M., Gu, W., Qiao, S.-B., Zhu, E., Zhao, Q., & Lv, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095463 · Cited by 49
Genetic Determinants of Arterial Calcification Associated With Atherosclerosis
Doherty, T. M., Fitzpatrick, L. A., Shaheen, A., Rajavashisth, T. B., & Detrano, R. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.2.197 · Cited by 49
Epidemiology of Vascular Dementia
Leys, D., Pasquier, F., & Parnetti, L. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022425 · Cited by 49
Apolipoprotein E genotype and plasma levels in coronary artery disease. A case-control study in the Italian population
Corbo, R. M., Vilardo, T., Ruggeri, M., Gemma, A. T., & Scacchi, R. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00011-9 · Cited by 48
0The Question Not Asked: The Challenge of Pleiotropic Genetic Tests
Wachbroit, R. (1998) · Kennedy Institute of Ethics journal · doi:10.1353/ken.1998.0013 · Cited by 48
The Relationship Between Risk Factor Levels and Presence of Coronary Artery Calcification is Dependent on Apolipoprotein E Genotype
Kardia, S. L. R., Haviland, M. B., Ferrell, R. E., & Sing, C. F. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.427 · Cited by 48
Serum Lipid and Antioxidant Responses in Hypercholesterolemic Men and Women Receiving Plant Sterol Esters Vary by Apolipoprotein E Genotype
Sánchez-Muniz, F. J., Maki, K. C., Schaefer, E. J., & Ordovás, J. M. (2008) · Journal of Nutrition · doi:10.3945/jn.108.090969 · Cited by 48
Apo E variants in patients with type III hyperlipoproteinemia
Civeira, F., Pocoví, M., Cenarro, A., Casao, E., Vilella, E., Joven, J., González, J., Garcia-Otín, A. L., & Ordovás, J. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05969-2 · Cited by 48
Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients
Sparks, D. L., Scheff, S. W., Liu, H., Landers, T. M., Danner, F., Coyne, C. M., & Hunsaker, J. C. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00008-1 · Cited by 48
apoE4 allele and the natural history of cardiovascular risk factors
Scuteri, A., Najjar, S. S., Muller, D. C., Andres, R., Morrell, C. H., Zonderman, A. B., & Lakatta, E. G. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00408.2004 · Cited by 48
Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there?
Rimbach, G. H., & Minihane, A. M. (2009) · Proceedings of The Nutrition Society · doi:10.1017/s0029665109001116 · Cited by 47
Gene–gene interaction of PPARγ and ApoE affects coronary heart disease risk
Peng, D., Zhao, S., Nie, S., & Jiang, L. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(03)00101-3 · Cited by 46
Apolipoprotein E Polymorphism and LDL Size in a Biethnic Population
Haffner, S. M., Stern, M. P., Miettinen, H., Robbins, D. C., & Howard, B. V. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.9.1184 · Cited by 46
The Underlying Molecular Mechanism of Apolipoprotein E Polymorphism: Relationships to Lipid Disorders, Cardiovascular Disease, and Alzheimer’s Disease
Contois, J. H., Anamani, D. E., & Tsongalis, G. J. (1996) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30290-7 · Cited by 45
Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study.
Meigs, J. B., Ordovás, J. M., Cupples, L. A., Singer, D. E., Nathan, D. M., Schaefer, E. J., & Wilson, P. W. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.669 · Cited by 45
Self-citation
APOE polymorphism and angiographic coronary artery disease severity in the Women's Ischemia Syndrome Evaluation (WISE) study
Chen, Q. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00160-6 · Cited by 44
Rapid westernization of children’s blood cholesterol in 3 countries: evidence for nutrient-gene interactions?
Couch, S. C., Cross, A. T., Kida, K., Ros, E., Plaza, I., Shea, S. A., & Deckelbaum, R. J. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.5.1266s · Cited by 43
Relationship between Severe Amyloid Angiopathy, Apolipoprotein E Genotype, and Vascular Lesions in Alzheimer's Disease
Olichney, J., Hansen, L. A., Lee, J. H., Hofstetter, C. R., Katzman, R., & Thal, L. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06360.x · Cited by 43
Plasma lipoproteins, apoproteins and cardiovascular disease in Type 2 diabetic patients. A nine-year follow-up study
della Rovere, G. R., Lapolla, A., Sartore, G., Rossetti, C., Zambon, S., Minicuci, N., Crepaldi, G., Fedele, D., & Manzato, E. (2003) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(03)80167-9 · Cited by 43
Modest Protective Effects of Isoflavones from a Red Clover-Derived Dietary Supplement on Cardiovascular Disease Risk Factors in Perimenopausal Women, and Evidence of an Interaction with ApoE Genotype in 49–65 Year-Old Women
Atkinson, C., Day, N., Stonehouse, W., Scollen, S., Loktionov, A., & Bingham, S. A. (2004) · Journal of Nutrition · doi:10.1093/jn/134.7.1759 · Cited by 43
Independent effects of the −219 G>T and ε2/ε3/ε4 polymorphisms in the apolipoprotein E gene on coronary artery disease: The Southampton Atherosclerosis Study
Ye, S., Dunleavey, L., Bannister, W. P., Day, L., Tapper, W., Collins, A. R., Day, I. N. M., & Simpson, I. A. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200983 · Cited by 43
Effects of apolipoprotein E genotypes and other risk factors on the development of coronary artery disease in Southern Turkey
Attila, G., Acartürk, E., Eskandari, G., Akpınar, O., Tuli, A., Kanadaşı, M., & Kayrın, L. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00624-6 · Cited by 43
Molecular genetics of myocardial infarction
Yamada, Y., Ichihara, S., & Nishida, T. (2008) · Genomic Medicine · doi:10.1007/s11568-008-9025-x · Cited by 42
Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136 → Ser) variant in multigenerational pedigree studies
Pocovi, M., Cenarro, A., Civeir, F., Myers, R. H., Casao, E., Esteban, M., & Ordovas, J. M. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)06745-0 · Cited by 42
Ionizing radiation and genetic risks
Sankaranarayanan, K., Chakraborty, R., & Boerwinkle, E. (1999) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(98)00017-9 · Cited by 42
Association between apolipoprotein E polymorphisms and premature coronary artery disease: a meta-analysis
Zhao, Q., Yu, L., Li, J., Jiang, N., & Shi, J. P. (2016) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2016-0145 · Cited by 40
Apolipoprotein E Polymorphisms and Postprandial Triglyceridemia Before and After Fenofibrate Treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN) Study
Irvin, M. R., Kabagambe, E. K., Tiwari, H. K., Parnell, L. D., Straka, R. J., Tsai, M. Y., Ordovás, J. M., & Arnett, D. K. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.950667 · Cited by 40
Apolipoprotein E and methylenetetrahydrofolate reductase genetic polymorphisms in relation to other risk factors for cardiovascular disease in UK Caucasians and Black South Africans
Loktionov, A., Vorster, H. H., O'Neill, I. K., Nell, T. A., Bingham, S. A., Runswick, S. A., & Cummings, J. H. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00022-2 · Cited by 40
Apolipoprotein E Genetic Polymorphism and Stroke Subtypes in a Bangladeshi Hospital-Based Study.
Chowdhury, A. H., Yokoyama, A., Kokubo, Y., Zaman, M. M., Haque, A., & Tanaka, H. (2001) · Journal of Epidemiology · doi:10.2188/jea.11.131 · Cited by 40
Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study
Grönroos, P. E., Raitakari, O. T., Kähönen, M. A. P., Hutri‐Kähönen, N., Marniemi, J., Viikari, J. S. A., & Lehtimäki, T. J. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.116 · Cited by 40
Gene–nutrient interactions: dietary behaviour associated with high coronary heart disease risk particularly affects serum LDL cholesterol in apolipoprotein E ε4-carrying free-living individuals
Loktionov, A., Scollen, S., McKeown, N. M., & Bingham, S. A. (2000) · British Journal Of Nutrition · doi:10.1017/s0007114500002506 · Cited by 39
Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study
Srinivasan, S. R., Ehnholm, C., Elkasabany, A., & Berenson, G. S. (2001) · Metabolism · doi:10.1053/meta.2001.23299 · Cited by 38
ApoE Gene Polymorphisms, BMD, and Fracture Risk in Elderly Men and Women: The Rotterdam Study
Schoofs, M. W. C. J., van der Klift, M., Albert Hofman, D., van Duijn, C. M., Stricker, B. H. C., Pols, H. A. P., & Uitterlinden, A. G. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040605 · Cited by 38
Frequency of phenotype-genotype discrepancies at the apolipoprotein E locus in a large population study
Lahoz, C., Osgood, D. P., Wilson, P. W., Schaefer, E. J., & Ordovás, J. M. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.11.1817 · Cited by 37
Self-citation
No Association of Pro12Ala Polymorphism of PPAR-.GAMMA. Gene With Coronary Artery Disease in Korean Subjects
Rhee, E., Kwon, C. H., Lee, W., Kim, S. Y., Jung, C., Kim, B. J., Sung, K., Kim, B. S., Oh, K. W., Kang, J. H., et al. (2007) · Circulation Journal · doi:10.1253/circj.71.338 · Cited by 37
Apolipoprotein E4 is associated with reduced calcaneal quantitative ultrasound measurements and bone mineral density in elderly women
Dick, I. M., Devine, A., Marangou, A., Dhaliwal, S. S., Laws, S. M., Martins, R. N., & Prince, R. L. (2002) · Bone · doi:10.1016/s8756-3282(02)00851-7 · Cited by 37
Impact of APOE gene polymorphisms on the lipid profile in an Algerian population
Boulenouar, H., Médiène-Benchekor, S., Meroufel, D. N., Lardjam-Hetraf, S. A., Ouhaïbi-Djellouli, H., Hermant, X., Grenier‐Boley, B., Hamani-Medjaoui, I., Saïdi‐Mehtar, N., Amouyel, P., et al. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-155 · Cited by 36
Influence of apolipoprotein E genotype on fat-soluble plasma antioxidants in Spanish children
Ortega, H., Castilla, P., Gómez‐Coronado, D., Garcés, C., Benavente, M., Rodríguez‐Artalejo, F., de Oya, M., & Lasunción, M. A. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.3.624 · Cited by 36
Apolipoprotein E Polymorphism Is Related to Plasma Lipids and Apolipoproteins in Mexican Adolescents
Medina-Urrutia, A. X., Cardoso-Saldaña, G. C., Zamora‐González, J., Yamamoto-Kimura, L. T., & Posadas‐Romero, C. (2004) · Human Biology · doi:10.1353/hub.2004.0059 · Cited by 35
Apolipoprotein E e4 allele frequency in patients with multiple system atrophy
Cairns, N. J., Atkinson, P. F., Kovács, T., Lees, A. J., Daniel, S. E., & Lantos, P. L. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13316-4 · Cited by 35
Saturated fat intake and alcohol consumption modulate the association between the APOE polymorphism and risk of future coronary heart disease: a nested case-control study in the Spanish EPIC cohort
Corella, D., Portolés, O., Arriola, L., Chirlaque, M. D., Barrricarte, A., Francès, F., Huerta, J. M., Larrañaga, N., Martínez, C., Martínez‐Camblor, P., et al. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.04.003 · Cited by 35
Gene Polymorphism and Coronary Risk Factors in Indian Population
Ashavaid, T. F., Shalia, K. K., Kondkar, A. A., Todur, S. P., Nair, K. G., & Nair, S. (2002) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2002.171 · Cited by 34

Authors: Wilson, P. W. F.
Corresponding author: Wilson, Peter W. F.
ORCID: Wilson, Peter W. F.
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 1994-12-07
Volume: 272
Issue: 21
Pages: 1666
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1994.03520210050031
OpenAlex: W4237709179
Cited by: 468
References: 59
Citations by year: 2025: 1 · 2024: 3 · 2023: 10 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 2 · 2017: 6 · 2016: 7 · 2015: 7 · 2014: 7 · 2013: 14 · 2012: 9
FWCI: 21.68
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords: apolipoprotein E, apolipoprotein E ε4 allele, dyslipidemia, coronary artery disease, LDL cholesterol, triglycerides, sex differences, genetic risk factors, Framingham Offspring Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks